Fertility and Sterility
Volume 92, Issue 1 , Pages 137-142 , July 2009

The impact of rescue in vitro fertilization converted from high-response gonadotropin intrauterine insemination cycles in terms of implantation and pregnancy rates as compared with matched controls

  • Bulent Haydardedeoglu, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Division of Reproductive and Endocrinology Unit, Adana, Turkey
    • Corresponding Author InformationReprint requests: Bulent Haydardedeoglu, M.D., Baskent University Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Reproductive and Endocrinology Unit, Cemalpasa mah 5 sokak ferah apt kat: 9 no:18 Seyhan, Adana, Turkey (FAX: 90-322-4599511).
  • ,
  • Tayfun Bagis, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Division of Reproductive and Endocrinology Unit, Adana, Turkey
  • ,
  • Erhan Simsek, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Adana, Turkey
  • ,
  • Tayfun Cok, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Division of Reproductive and Endocrinology Unit, Adana, Turkey
  • ,
  • Servet Ozden Hacivelioglu, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Adana, Turkey
  • ,
  • Serkan Erkanli, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Adana, Turkey

Received 30 March 2008 ,Revised 12 May 2008 ,Accepted 21 May 2008.

References 

  1. Karande VC, Korn A, Morris R, Rao R, Balin M, Rinehart J, et al. Prospective randomized trial comparing the outcome and cost of in vitro fertilization with that of a traditional treatment algorithm as first-line therapy for couples with infertility. Fertil Steril. 1999;71:468–475
  2. Pashayan N, Lyratzopoulos G, Mathur R. Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertility. BMC Health Serv Res. 2006;6:80
  3. Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, et al. Efficacy of treatment for unexplained infertility. Fertil Steril. 1998;70:207–213
  4. Valbuena D, Simon C, Romero J, Remohi J, Pellicer A. Factors responsible for multiple pregnancies after ovarian stimulation and intrauterine insemination with gonadotropins. J Assist Reprod Genet. 1996;13:663–668
  5. Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update. 2006;12:651–671
  6. Nisker J, Tummon I, Daniel S, Kaplan B, Yuzpe A. Conversion of cycles involving ovarian hyperstimulation with intrauterine insemination to in-vitro fertilisation. Hum Reprod. 1994;9:406–408
  7. Antman AM, Politch JA, Ginsburg ES. Conversion of high-response gonadotropin intrauterine insemination cycles to in-vitro fertilization results in excellent ongoing pregnancy rates. Fertil Steril. 2002;77:715–722
  8. Olufowobi O, Sharif K, Papaioannou S, Mohamed H, Neelakantan M, Afnan M. Role of rescue IVF-ET treatment in the management of high response in stimulated IUI cycles. J Obstet Gynaecol. 2005;25:166–168
  9. Smitz J, Ron-El R, Tarlatzis BC. The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres. Hum Reprod. 1992;7(Suppl 1):49–66
  10. Maroulis G, Saphier A, Emery M, Bernhisel M, Verkauf B, Yeko T. Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocol for in vitro fertilization. Fertil Steril. 1991;55:1157–1164
  11. Vani S, McDonald SE, Williams AR, Mason JI, Thong KJ, Critchley HO. Mid-luteal endometrial intracrinology following controlled ovarian hyperstimulation involving use of a gonadotrophin releasing hormone antagonist. Hum Reprod. 2007;22:2981–2991
  12. Griesinger G, Felberbaum R, Diedrich K. GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry. Hum Reprod. 2005;20:2373–2375
  13. Fauser BC, Devroey P. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?. Fertil Steril. 2005;83:1607–1611
  14. De Diegler D, Fanchin R, de Moustier B, Bulletti C. The hormonal control of endometrium receptivity: estrogen (E2) and progesterone. J Reprod Immunol. 1998;39:149–166
  15. Levi AJ, Drews MR, Bergh PA, Miller BT, Scott RT. Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles. Fertil Steril. 2001;76:670–674
  16. Polinder S, Heijnen EM, Macklon NS, Habbema JD, Fauser BJ, Eijkemans MJ. Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint. Hum Reprod. 2008;23:316–323
  17. Heijnen EM, Eijkemans MJ, De Klerk C, Polinder S, Beckers NG, Klinkert ER, et al. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet. 2007;369:743–749
  18. Pandian Z, Templeton A, Serour G, Bhattacharya S. Number of embryos for transfer after IVF and ICSI: a Cochrane review. Hum Reprod. 2005;20:2681–2687
  19. National Collaborating Centre for Women's Children's Health . Fertility: assessment and treatment for people with fertility problems. Clinical Guideline. London: RCOG Press; 2004;

 B.H. has nothing to disclose. T.B. has nothing to disclose. E.S. has nothing to disclose. T.C. has nothing to disclose. C.O.H. has nothing to disclose. S.E. has nothing to disclose.

PII: S0015-0282(08)01233-8

doi: 10.1016/j.fertnstert.2008.05.077

Fertility and Sterility
Volume 92, Issue 1 , Pages 137-142 , July 2009